The share of scientific publications among the world's top 10% cited in pulmonary and respiratory medicine in Canada stood at 14.9% in 2023. Based on 2024 forecasted data, this share is expected to increase to 15.4%, representing a year-on-year increase of 3.36%. The following years continue this upward trajectory with anticipated shares of 15.58% in 2025, 15.73% in 2026, 15.84% in 2027, and 15.93% in 2028. The compound annual growth rate (CAGR) over the five-year forecast period is expected to be around 1.66%.

Future trends to watch for:

Investigate factors contributing to Canada's growing influence in this sector, including funding increases and collaborative research efforts.
Monitor advancements in healthcare technologies that may influence publication impact and citation rates.
Evaluate the potential impacts of global health challenges on scientific output and citation metrics.